iSonea snags $13.5M; NeuroMetrix rises on FDA clearance;

@FierceMedDev:  ICYM this week's M&A feature - Blockbusters and bloodlettings: A look at 2013's hot start. Special report | Follow @FierceMedDev

 @MarkHFierce: Only a few weeks left to nominate a company for this year's FMD Fierce 15. Submit your nomination | Follow @MarkHFierce

@DamianFierce: Device outfit CVRx has raised $29.6M in a round led by NEA and J&J. Article | Follow @DamianFierce

> Maryland's iSonea raised $13.5 million to market AirSonea, a personal monitoring device that detects airway obstruction in asthma. Release

> NeuroMetrix ($NURO) enjoyed a big bump in its stock price after gaining 510(k) clearance to use its pain-management device during sleep on diabetic patients. Story

> The FDA has assigned its most serious Class I recall label to Verathon's GlideScope Video Laryngoscope, warning that the device's reusable blades can break off and damage patients' airways. More

> California startup SynGen raised $2 million in financing to help advance development of a stem cell harvesting device. Story

> St. Jude Medical's ($STJ) Accent MRI pacemaker, launched recently in Japan, should help the company regain lost market share in the global cardiac rhythm management space, some speculate. Item

> Quest Diagnostics ($DGX) has teamed up with the Centers for Disease Control and Prevention (CDC) to promote hepatitis C screening. News

> Devicemaker Minnetronix has acquired Neurofluidics, a neurocritical care technology specialist. Release

> PathoQuest attracted $5 million in a series B private equity round--money that will help continue development of its diagnostic that relies on next-generation sequencing and cloud-based analysis software. Story (reg. req.)

Biotech News

@FierceBiotech: 2013 Biotech IPOs: The biotech IPO scene turns red hot. Special report | Follow @FierceBiotech

 @JohnCFierce: Deborah Dunsire makes quick leap from Millennium to fast-growing EnVivo. News | Follow @JohnCFierce

@RyanMFierce: Alnylam Pharma spotlights more upbeat human data for gene-silencing drugs. Story | Follow @RyanMFierce

 @EmilyMFierce: Antileukemia compound could also treat common breast cancers. Story | Follow @EmilyMFierce

> Rockwell Medical shares spike on positive PhIII data. Item

> EU, pharma industry pledge $4.4B for R&D projects. Story

> Booming China poised to take a top position in global drug R&D. Article

Pharma News

@FiercePharma: Pharma, FDA still lag in postmarketing safety studies. Getting better, but large % unfinished--or not begun. Yesterday's story | Follow @FiercePharma

 @CarlyHFierce: NICE says 'no' to Celgene's Revlimid. Article | Follow @CarlyHFierce

> New problems for GSK in China as authorities say GSK employees confess to bribery. News

> Vivus hooks up with Menarini to hawk ED pill Spedra in $121M deal. More

Pharma Manufacturing News

 @EricPFierce: BioPlan says China, India losing luster for outsourced biopharmaceutical manufacturing. More | Follow @EricPFierce

> Wockhardt faces 2nd import alert. Report

> Sanofi's ImmuCyst available in next year, Alliance Pharma says. More

> Pfizer to invest $130M in 2 plants in Ireland. News

> Contract manufacturer Piramal also into development, cellphones. Story

Vaccines News

> Manufacturers prepare for resurgence of H7N9. News

> Robot eases kids' vaccination distress in study. More

> Novartis inks typhoid vax licensing deal with Biological E. Story

> U.K. mumps outbreak linked to waning MMR protection. Report